High Throughput Sequencing for Clinical Tuberculosis: An Overview

High throughput sequencing (HTS) can identify the presence of Mycobacterium tuberculosis DNA in a clinical sample while also providing information on drug susceptibility. Multiple studies have provided a context for exploring the clinical application of HTS for TB diagnosis. The workflow challenges, strengths and limitations of the various sequencing platforms, and tools used for analysis are presented to provide a framework for further innovations in the field.

• Publication year

  2022

• Venue

  Pathogens

• Publication date

  2022-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/pathogens11111343PMID 36422596PMCID 9695813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

  2022cited by this paper
• GitHub

  2022cited by this paper
• Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens

  2022cited by this paper
• Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing

  2022influential reference
• Rapid Identification of Drug-Resistant Tuberculosis Genes Using Direct PCR Amplification and Oxford Nanopore Technology Sequencing

  2022cited by this paper
• Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes

  2021cited by this paper
• First molecular-based anti-TB drug resistance survey in Eritrea.

  2021cited by this paper
• Whole-genome sequencing differentiates relapse from re-infection in TB.

  2021cited by this paper
• A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing

  2021cited by this paper
• Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country

  2021cited by this paper
• Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis.

  2021cited by this paper
• Previously undetected super-spreading of Mycobacterium tuberculosis revealed by deep sequencing

  2020cited by this paper
• Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples

  2020cited by this paper
• Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo

  2020cited by this paper
• Library preparation for next generation sequencing: A review of automation strategies.

  2020cited by this paper
• Exact mapping of Illumina blind spots in the Mycobacterium tuberculosis genome reveals platform-wide and workflow-specific biases

  2020cited by this paper
• Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears

  2020cited by this paper
• Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Performance, Turnaround Time, and Cost.

  2020cited by this paper
• Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study.

  2020cited by this paper
• Assessing Nanopore Sequencing for Clinical Diagnostics: a Comparison of Next-Generation Sequencing (NGS) Methods for Mycobacterium tuberculosis

  2020cited by this paper
• Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis

  2020cited by this paper
• Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs

  2020cited by this paper
• Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB

  2020cited by this paper
• Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe

  2019cited by this paper
• Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward

  2019cited by this paper
• Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

  2019influential reference
• Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing

  2019cited by this paper
• Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

  2019cited by this paper
• Utility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana

  2019cited by this paper
• Accuracy

  2019cited by this paper
• Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture

  2018cited by this paper
• MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates

  2018cited by this paper
• Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey

  2017cited by this paper
• What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis

  2017cited by this paper
• Preservation of sputum samples with cetylpyridinium chloride (CPC) for tuberculosis cultures and Xpert MTB/RIF in a low-income country

  2017cited by this paper
• Detection of first and second line drug resistance mutations from multi drug resistantmycobacterium tuberculosisstrains by Ion Torrent whole genome sequencing (WGS)

  2016cited by this paper
• Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

  2016cited by this paper
• Mycobacterial DNA Extraction for Whole-Genome Sequencing from Early Positive Liquid (MGIT) Cultures

  2015cited by this paper
• Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

  2015cited by this paper
• PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data

  2015cited by this paper
• Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

  2015cited by this paper
• Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement

  2014cited by this paper
• Whole-Genome-Based Mycobacterium tuberculosis Surveillance: a Standardized, Portable, and Expandable Approach

  2014cited by this paper
• KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes

  2014cited by this paper
• Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

  2013cited by this paper
• Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis.

  2013cited by this paper
• Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study

  2012cited by this paper
• Next-Generation Ion Torrent Sequencing of Drug Resistance Mutations in Mycobacterium tuberculosis Strains

  2012cited by this paper
• Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

  1998cited by this paper

• Systematic review and meta-analysis of protocols and sequencing yield for whole genome sequencing of Mycobacterium tuberculosis directly from sputum samples.

  2026cites this paper
• Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples - An update.

  2025cites this paper
• Rapid Diagnostic Sequencing of Stool DNA Using Targeted Nanopore Sequencing in Patients With a Pulmonary Tuberculosis Diagnosis

  2025cites this paper
• Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science

  2025cites this paper
• Contemporary review on Metabolomic applications towards biomarker discovery and tuberculosis diagnosis

  2025cites this paper
• A preliminary study on the clinical value of simultaneous amplification and testing for tuberculosis (SAT-TB) for early therapeutic monitoring in multidrug-resistant/rifampicin-resistant tuberculosis

  2025cites this paper
• Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis

  2025cites this paper
• Single‐cell sequencing: Current applications in various tuberculosis specimen types

  2024cites this paper
• Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches

  2024cites this paper
• Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape

  2024cites this paper
• Systematic review and meta-analysis of protocols and yield of direct from sputum sequencing of Mycobacterium tuberculosis

  2024cites this paper
• Application of Metagenomic High-Throughput Sequencing in a Rare Case of Multisite Infection With Two Microorganisms After Total Knee Arthroplasty.

  2023cites this paper
• Rolling out new anti-tuberculosis drugs without diagnostic capacity

  2023cites this paper
• Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies

  2023cites this paper